ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 104

Identification of Joints with Active Arthritis from Clinical Notes with High Fidelity using a Large Language Model

Marc Natter1, Seungwon Lee2, Min-Lee Chang3 and Mei-Sing Ong1, 1Boston Children's Hospital, Boston, MA, 2Boston Children's Hospital, 3Boston Children's Hospital, MA

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Friday, March 20, 2026

Title: Abstracts: Technology

Session Time: 4:49PM-4:54PM

Background/Purpose: Accumulating evidence supports a new, biology-driven classification system for JIA diagnosis and prognosis, depending upon identification of patterns of arthritis involvement, rather than just total active joint count. Abstraction of active joints for clinical research has traditionally relied upon labor-intensive, manual chart review and can require significant domain expertise. As such, even some large clinical observational study efforts, such as the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry, routinely only collect the total active joint count, rather than specific joints involved. Recent advances in Large Language Models (LLMs) offer a transformative opportunity to automate and economize this process.

Methods: Our approach employed a structured LLM context utilizing an 83-joint list for classification of arthritis activity in an approach incorporating note section prioritization, edge-case handling, and temporal constraints. Output was structured to include joint identity, classification confidence (low, intermediate, high) and reasoning notes. We utilized GPT-5 (OpenAI, San Francisco, CA) within an internal, HIPAA-compliant instance at Boston Children’s Hospital (BCH). We randomly selected ambulatory notes for patients with JIA from 2017 to 2024. The LLM response was compared against a gold standard derived from expert annotation by a pediatric rheumatologist.

Results: 41 outpatient clinical notes from patients fulfilling ILAR criteria for JIA were identified and classified. The median active joint count was 1, with a range of 0 to 18. The total active joint count was correct in 34 cases, achieving 83% accuracy. When examining individual joints across all cases, the LLM correctly identified 118 affected joints (recall = 87.4%, precision = 85.5%); 20 joints were incorrectly identified as affected (false positive rate = 0.6%) and 17 joints were incorrectly identified as unaffected (false negative rate = 12.6%, specificity = 99.4%). False positives were predominantly due to ambiguous exam documentation (e.g. ‘all fingers swollen’, leading to all MCPs, IPs and PIPs, and DIPs being counted) and ranked as low confidence by the LLM. False negatives were almost entirely due to contradictory information between physical exam and assessment documentation.

Conclusion: Natural language processing of clinical notes from pediatric rheumatology visits was highly performant in identifying active joints using the GPT-5 LLM, with only modest effort required by a domain expert for context engineering for this task. This is consistent with other analysis tasks for state-of-the-art generative LLMs, which are often highly performant at using a ‘zero shot’ (no examples provided) approach. The LLM’s capability to provide confidence levels and explanatory reasoning is likely to offer greatly reduced research coordinator burden for such tasks, as ambiguous or other low-confidence results can be selectively reviewed on a manual basis. We suspect that many other manually-intensive chart abstraction activities for observational clinical studies in pediatric rheumatology may be similarly amenable to automation.


Disclosures: M. Natter: GE Healthcare, 12, Stock ownership (spouse), Walgreens Boots Alliance, 12, Stock holdings (spouse); S. Lee: None; M. Chang: None; M. Ong: None.

To cite this abstract in AMA style:

Natter M, Lee S, Chang M, Ong M. Identification of Joints with Active Arthritis from Clinical Notes with High Fidelity using a Large Language Model [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/identification-of-joints-with-active-arthritis-from-clinical-notes-with-high-fidelity-using-a-large-language-model/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-joints-with-active-arthritis-from-clinical-notes-with-high-fidelity-using-a-large-language-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology